Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaofei Tong

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Biological Macromolecules|June 21, 2026
Fusion peptide-functionalized amniotic membrane scaffold promotes diabetic burn repair by modulating neurovascular couplingZhenyang Xiao, Shuyue Chen, Huiyi Luo, et al.
Frontiers in Surgery|September 5, 2022
Postoperative antibiotics and infection rates after implant-based breast reconstruction: A systematic review and meta-analysisYang Hu, Xuan Zhou, Xiaofei Tong, et al.
Hepatology (Baltimore, Md.)|March 19, 2026
ECM1 produced by hepatic stellate cells serves as gate keeper of liver homeostasis in hepatic fibrosisAiting Yang, Xuzhen Yan, Yiwen Wang, et al.
Abdominal Radiology (New York)|March 10, 2024
Intravoxel incoherent motion assessment of liver fibrosis staging in MASLDHao Ren, Hui Xu, Dawei Yang, et al.
Heliyon|February 5, 2024
The staging of nonalcoholic fatty liver disease fibrosis: A comparative study of MR elastography and the quantitative DCE-MRI exchange modelHao Ren, Dawei Yang, Hui Xu, et al.
The American Journal of Pathology|March 12, 2013
Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosisMin Cong, Tianhui Liu, Ping Wang, et al.
Chinese Medicine|February 24, 2023
Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trialJingjie Zhao, Qianyi Wang, Xinyu Zhao, et al.
Hepatology International|August 16, 2024
Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosisXiaofei Tong, Yameng Sun, Qianyi Wang, et al.
Hepatology (Baltimore, Md.)|July 28, 2025
Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled studyYameng Sun, Cuisong Wu, Guijie Xin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 27, 2025
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLDXiao-Dong Zhou, Yu-Ting Li, Seung Up Kim, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Biological Macromolecules|June 21, 2026
Fusion peptide-functionalized amniotic membrane scaffold promotes diabetic burn repair by modulating neurovascular couplingZhenyang Xiao, Shuyue Chen, Huiyi Luo, et al.
Frontiers in Surgery|September 5, 2022
Postoperative antibiotics and infection rates after implant-based breast reconstruction: A systematic review and meta-analysisYang Hu, Xuan Zhou, Xiaofei Tong, et al.
Hepatology (Baltimore, Md.)|March 19, 2026
ECM1 produced by hepatic stellate cells serves as gate keeper of liver homeostasis in hepatic fibrosisAiting Yang, Xuzhen Yan, Yiwen Wang, et al.
Abdominal Radiology (New York)|March 10, 2024
Intravoxel incoherent motion assessment of liver fibrosis staging in MASLDHao Ren, Hui Xu, Dawei Yang, et al.
Heliyon|February 5, 2024
The staging of nonalcoholic fatty liver disease fibrosis: A comparative study of MR elastography and the quantitative DCE-MRI exchange modelHao Ren, Dawei Yang, Hui Xu, et al.
The American Journal of Pathology|March 12, 2013
Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosisMin Cong, Tianhui Liu, Ping Wang, et al.
Chinese Medicine|February 24, 2023
Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trialJingjie Zhao, Qianyi Wang, Xinyu Zhao, et al.
Hepatology International|August 16, 2024
Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosisXiaofei Tong, Yameng Sun, Qianyi Wang, et al.
Hepatology (Baltimore, Md.)|July 28, 2025
Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled studyYameng Sun, Cuisong Wu, Guijie Xin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 27, 2025
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLDXiao-Dong Zhou, Yu-Ting Li, Seung Up Kim, et al.
Pageof 3